nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—CYP2D6—Niacin—atherosclerosis	0.141	0.3	CbGbCtD
Betaxolol—CYP2D6—Simvastatin—atherosclerosis	0.112	0.237	CbGbCtD
Betaxolol—CYP2D6—Lovastatin—atherosclerosis	0.109	0.232	CbGbCtD
Betaxolol—CYP2D6—Pravastatin—atherosclerosis	0.109	0.232	CbGbCtD
Betaxolol—Malnutrition—Ezetimibe—atherosclerosis	0.000996	0.00212	CcSEcCtD
Betaxolol—Dysgeusia—Lovastatin—atherosclerosis	0.000994	0.00212	CcSEcCtD
Betaxolol—Rhinitis—Pravastatin—atherosclerosis	0.000989	0.00211	CcSEcCtD
Betaxolol—Confusional state—Rosuvastatin—atherosclerosis	0.000986	0.0021	CcSEcCtD
Betaxolol—Hypoaesthesia—Pravastatin—atherosclerosis	0.000982	0.00209	CcSEcCtD
Betaxolol—Pharyngitis—Pravastatin—atherosclerosis	0.000979	0.00209	CcSEcCtD
Betaxolol—Chills—Simvastatin—atherosclerosis	0.000979	0.00209	CcSEcCtD
Betaxolol—Muscle spasms—Lovastatin—atherosclerosis	0.000976	0.00208	CcSEcCtD
Betaxolol—Infection—Rosuvastatin—atherosclerosis	0.000972	0.00207	CcSEcCtD
Betaxolol—Visual impairment—Niacin—atherosclerosis	0.000966	0.00206	CcSEcCtD
Betaxolol—Alopecia—Simvastatin—atherosclerosis	0.000964	0.00206	CcSEcCtD
Betaxolol—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000959	0.00205	CcSEcCtD
Betaxolol—Muscle spasms—Ezetimibe—atherosclerosis	0.000958	0.00204	CcSEcCtD
Betaxolol—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000958	0.00204	CcSEcCtD
Betaxolol—Vision blurred—Lovastatin—atherosclerosis	0.000957	0.00204	CcSEcCtD
Betaxolol—Mental disorder—Simvastatin—atherosclerosis	0.000956	0.00204	CcSEcCtD
Betaxolol—Tremor—Lovastatin—atherosclerosis	0.000951	0.00203	CcSEcCtD
Betaxolol—Visual impairment—Pravastatin—atherosclerosis	0.000951	0.00203	CcSEcCtD
Betaxolol—Erythema—Simvastatin—atherosclerosis	0.00095	0.00203	CcSEcCtD
Betaxolol—Ill-defined disorder—Lovastatin—atherosclerosis	0.000942	0.00201	CcSEcCtD
Betaxolol—Eye disorder—Niacin—atherosclerosis	0.000936	0.002	CcSEcCtD
Betaxolol—Tinnitus—Niacin—atherosclerosis	0.000934	0.00199	CcSEcCtD
Betaxolol—Dysgeusia—Simvastatin—atherosclerosis	0.00093	0.00198	CcSEcCtD
Betaxolol—Flushing—Niacin—atherosclerosis	0.00093	0.00198	CcSEcCtD
Betaxolol—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000924	0.00197	CcSEcCtD
Betaxolol—Anaemia—Ezetimibe—atherosclerosis	0.000921	0.00196	CcSEcCtD
Betaxolol—Tinnitus—Pravastatin—atherosclerosis	0.00092	0.00196	CcSEcCtD
Betaxolol—Malaise—Lovastatin—atherosclerosis	0.000916	0.00195	CcSEcCtD
Betaxolol—Cardiac disorder—Pravastatin—atherosclerosis	0.000916	0.00195	CcSEcCtD
Betaxolol—Flushing—Pravastatin—atherosclerosis	0.000916	0.00195	CcSEcCtD
Betaxolol—Muscle spasms—Simvastatin—atherosclerosis	0.000913	0.00195	CcSEcCtD
Betaxolol—Vertigo—Lovastatin—atherosclerosis	0.000912	0.00195	CcSEcCtD
Betaxolol—Angiopathy—Niacin—atherosclerosis	0.000909	0.00194	CcSEcCtD
Betaxolol—Chills—Niacin—atherosclerosis	0.000899	0.00192	CcSEcCtD
Betaxolol—Malaise—Ezetimibe—atherosclerosis	0.000898	0.00192	CcSEcCtD
Betaxolol—Vision blurred—Simvastatin—atherosclerosis	0.000895	0.00191	CcSEcCtD
Betaxolol—Arrhythmia—Niacin—atherosclerosis	0.000895	0.00191	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000891	0.0019	CcSEcCtD
Betaxolol—Tremor—Simvastatin—atherosclerosis	0.00089	0.0019	CcSEcCtD
Betaxolol—Alopecia—Niacin—atherosclerosis	0.000885	0.00189	CcSEcCtD
Betaxolol—Chills—Pravastatin—atherosclerosis	0.000885	0.00189	CcSEcCtD
Betaxolol—Insomnia—Rosuvastatin—atherosclerosis	0.000885	0.00189	CcSEcCtD
Betaxolol—Ill-defined disorder—Simvastatin—atherosclerosis	0.000881	0.00188	CcSEcCtD
Betaxolol—Arrhythmia—Pravastatin—atherosclerosis	0.000881	0.00188	CcSEcCtD
Betaxolol—Palpitations—Ezetimibe—atherosclerosis	0.00088	0.00188	CcSEcCtD
Betaxolol—Paraesthesia—Rosuvastatin—atherosclerosis	0.000878	0.00187	CcSEcCtD
Betaxolol—Anaemia—Simvastatin—atherosclerosis	0.000878	0.00187	CcSEcCtD
Betaxolol—Erythema—Niacin—atherosclerosis	0.000872	0.00186	CcSEcCtD
Betaxolol—Malnutrition—Niacin—atherosclerosis	0.000872	0.00186	CcSEcCtD
Betaxolol—Alopecia—Pravastatin—atherosclerosis	0.000872	0.00186	CcSEcCtD
Betaxolol—Cough—Ezetimibe—atherosclerosis	0.000869	0.00185	CcSEcCtD
Betaxolol—Myalgia—Lovastatin—atherosclerosis	0.000865	0.00184	CcSEcCtD
Betaxolol—Chest pain—Lovastatin—atherosclerosis	0.000865	0.00184	CcSEcCtD
Betaxolol—Arthralgia—Lovastatin—atherosclerosis	0.000865	0.00184	CcSEcCtD
Betaxolol—Anxiety—Lovastatin—atherosclerosis	0.000862	0.00184	CcSEcCtD
Betaxolol—Dyspepsia—Rosuvastatin—atherosclerosis	0.000861	0.00184	CcSEcCtD
Betaxolol—Malaise—Simvastatin—atherosclerosis	0.000857	0.00183	CcSEcCtD
Betaxolol—Tension—Niacin—atherosclerosis	0.000856	0.00183	CcSEcCtD
Betaxolol—Discomfort—Lovastatin—atherosclerosis	0.000854	0.00182	CcSEcCtD
Betaxolol—Vertigo—Simvastatin—atherosclerosis	0.000853	0.00182	CcSEcCtD
Betaxolol—Myalgia—Ezetimibe—atherosclerosis	0.000848	0.00181	CcSEcCtD
Betaxolol—Chest pain—Ezetimibe—atherosclerosis	0.000848	0.00181	CcSEcCtD
Betaxolol—Arthralgia—Ezetimibe—atherosclerosis	0.000848	0.00181	CcSEcCtD
Betaxolol—Nervousness—Niacin—atherosclerosis	0.000847	0.00181	CcSEcCtD
Betaxolol—Dry mouth—Lovastatin—atherosclerosis	0.000846	0.0018	CcSEcCtD
Betaxolol—Tension—Pravastatin—atherosclerosis	0.000843	0.0018	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000842	0.0018	CcSEcCtD
Betaxolol—Dysgeusia—Pravastatin—atherosclerosis	0.000841	0.00179	CcSEcCtD
Betaxolol—Muscle spasms—Niacin—atherosclerosis	0.000839	0.00179	CcSEcCtD
Betaxolol—Discomfort—Ezetimibe—atherosclerosis	0.000838	0.00179	CcSEcCtD
Betaxolol—Constipation—Rosuvastatin—atherosclerosis	0.000836	0.00178	CcSEcCtD
Betaxolol—Pain—Rosuvastatin—atherosclerosis	0.000836	0.00178	CcSEcCtD
Betaxolol—Confusional state—Lovastatin—atherosclerosis	0.000836	0.00178	CcSEcCtD
Betaxolol—Nervousness—Pravastatin—atherosclerosis	0.000834	0.00178	CcSEcCtD
Betaxolol—Dry mouth—Ezetimibe—atherosclerosis	0.000829	0.00177	CcSEcCtD
Betaxolol—Muscle spasms—Pravastatin—atherosclerosis	0.000826	0.00176	CcSEcCtD
Betaxolol—Infection—Lovastatin—atherosclerosis	0.000823	0.00176	CcSEcCtD
Betaxolol—Vision blurred—Niacin—atherosclerosis	0.000822	0.00175	CcSEcCtD
Betaxolol—Confusional state—Ezetimibe—atherosclerosis	0.00082	0.00175	CcSEcCtD
Betaxolol—Thrombocytopenia—Lovastatin—atherosclerosis	0.000811	0.00173	CcSEcCtD
Betaxolol—Vision blurred—Pravastatin—atherosclerosis	0.000809	0.00173	CcSEcCtD
Betaxolol—Myalgia—Simvastatin—atherosclerosis	0.000809	0.00172	CcSEcCtD
Betaxolol—Chest pain—Simvastatin—atherosclerosis	0.000809	0.00172	CcSEcCtD
Betaxolol—Arthralgia—Simvastatin—atherosclerosis	0.000809	0.00172	CcSEcCtD
Betaxolol—Infection—Ezetimibe—atherosclerosis	0.000808	0.00172	CcSEcCtD
Betaxolol—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000806	0.00172	CcSEcCtD
Betaxolol—Anxiety—Simvastatin—atherosclerosis	0.000806	0.00172	CcSEcCtD
Betaxolol—Tremor—Pravastatin—atherosclerosis	0.000805	0.00172	CcSEcCtD
Betaxolol—Discomfort—Simvastatin—atherosclerosis	0.000799	0.0017	CcSEcCtD
Betaxolol—Nervous system disorder—Ezetimibe—atherosclerosis	0.000797	0.0017	CcSEcCtD
Betaxolol—Ill-defined disorder—Pravastatin—atherosclerosis	0.000797	0.0017	CcSEcCtD
Betaxolol—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000796	0.0017	CcSEcCtD
Betaxolol—Anaemia—Pravastatin—atherosclerosis	0.000794	0.00169	CcSEcCtD
Betaxolol—Anorexia—Lovastatin—atherosclerosis	0.00079	0.00168	CcSEcCtD
Betaxolol—Skin disorder—Ezetimibe—atherosclerosis	0.00079	0.00168	CcSEcCtD
Betaxolol—Vertigo—Niacin—atherosclerosis	0.000784	0.00167	CcSEcCtD
Betaxolol—Syncope—Niacin—atherosclerosis	0.000782	0.00167	CcSEcCtD
Betaxolol—Confusional state—Simvastatin—atherosclerosis	0.000782	0.00167	CcSEcCtD
Betaxolol—Urticaria—Rosuvastatin—atherosclerosis	0.000777	0.00166	CcSEcCtD
Betaxolol—Oedema—Simvastatin—atherosclerosis	0.000775	0.00165	CcSEcCtD
Betaxolol—Malaise—Pravastatin—atherosclerosis	0.000774	0.00165	CcSEcCtD
Betaxolol—Vertigo—Pravastatin—atherosclerosis	0.000772	0.00165	CcSEcCtD
Betaxolol—Palpitations—Niacin—atherosclerosis	0.000771	0.00164	CcSEcCtD
Betaxolol—Infection—Simvastatin—atherosclerosis	0.00077	0.00164	CcSEcCtD
Betaxolol—Loss of consciousness—Niacin—atherosclerosis	0.000767	0.00164	CcSEcCtD
Betaxolol—Cough—Niacin—atherosclerosis	0.000761	0.00162	CcSEcCtD
Betaxolol—Thrombocytopenia—Simvastatin—atherosclerosis	0.000759	0.00162	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000755	0.00161	CcSEcCtD
Betaxolol—Insomnia—Lovastatin—atherosclerosis	0.00075	0.0016	CcSEcCtD
Betaxolol—Cough—Pravastatin—atherosclerosis	0.000749	0.0016	CcSEcCtD
Betaxolol—Paraesthesia—Lovastatin—atherosclerosis	0.000744	0.00159	CcSEcCtD
Betaxolol—Myalgia—Niacin—atherosclerosis	0.000743	0.00158	CcSEcCtD
Betaxolol—Arthralgia—Niacin—atherosclerosis	0.000743	0.00158	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000741	0.00158	CcSEcCtD
Betaxolol—Anorexia—Simvastatin—atherosclerosis	0.000739	0.00158	CcSEcCtD
Betaxolol—Dyspnoea—Lovastatin—atherosclerosis	0.000739	0.00158	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000737	0.00157	CcSEcCtD
Betaxolol—Insomnia—Ezetimibe—atherosclerosis	0.000735	0.00157	CcSEcCtD
Betaxolol—Arthralgia—Pravastatin—atherosclerosis	0.000731	0.00156	CcSEcCtD
Betaxolol—Myalgia—Pravastatin—atherosclerosis	0.000731	0.00156	CcSEcCtD
Betaxolol—Chest pain—Pravastatin—atherosclerosis	0.000731	0.00156	CcSEcCtD
Betaxolol—Paraesthesia—Ezetimibe—atherosclerosis	0.00073	0.00156	CcSEcCtD
Betaxolol—Dyspepsia—Lovastatin—atherosclerosis	0.00073	0.00156	CcSEcCtD
Betaxolol—Anxiety—Pravastatin—atherosclerosis	0.000729	0.00155	CcSEcCtD
Betaxolol—Dry mouth—Niacin—atherosclerosis	0.000726	0.00155	CcSEcCtD
Betaxolol—Dyspnoea—Ezetimibe—atherosclerosis	0.000725	0.00155	CcSEcCtD
Betaxolol—Discomfort—Pravastatin—atherosclerosis	0.000722	0.00154	CcSEcCtD
Betaxolol—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000721	0.00154	CcSEcCtD
Betaxolol—Decreased appetite—Lovastatin—atherosclerosis	0.00072	0.00154	CcSEcCtD
Betaxolol—Dyspepsia—Ezetimibe—atherosclerosis	0.000716	0.00153	CcSEcCtD
Betaxolol—Fatigue—Lovastatin—atherosclerosis	0.000715	0.00152	CcSEcCtD
Betaxolol—Oedema—Niacin—atherosclerosis	0.000712	0.00152	CcSEcCtD
Betaxolol—Constipation—Lovastatin—atherosclerosis	0.000709	0.00151	CcSEcCtD
Betaxolol—Pain—Lovastatin—atherosclerosis	0.000709	0.00151	CcSEcCtD
Betaxolol—Confusional state—Pravastatin—atherosclerosis	0.000707	0.00151	CcSEcCtD
Betaxolol—Decreased appetite—Ezetimibe—atherosclerosis	0.000707	0.00151	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000706	0.00151	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000702	0.0015	CcSEcCtD
Betaxolol—Asthenia—Rosuvastatin—atherosclerosis	0.000702	0.0015	CcSEcCtD
Betaxolol—Insomnia—Simvastatin—atherosclerosis	0.000701	0.0015	CcSEcCtD
Betaxolol—Oedema—Pravastatin—atherosclerosis	0.000701	0.00149	CcSEcCtD
Betaxolol—Fatigue—Ezetimibe—atherosclerosis	0.000701	0.00149	CcSEcCtD
Betaxolol—Shock—Niacin—atherosclerosis	0.0007	0.00149	CcSEcCtD
Betaxolol—Infection—Pravastatin—atherosclerosis	0.000696	0.00149	CcSEcCtD
Betaxolol—Paraesthesia—Simvastatin—atherosclerosis	0.000696	0.00148	CcSEcCtD
Betaxolol—Pain—Ezetimibe—atherosclerosis	0.000695	0.00148	CcSEcCtD
Betaxolol—Constipation—Ezetimibe—atherosclerosis	0.000695	0.00148	CcSEcCtD
Betaxolol—Tachycardia—Niacin—atherosclerosis	0.000695	0.00148	CcSEcCtD
Betaxolol—Pruritus—Rosuvastatin—atherosclerosis	0.000692	0.00148	CcSEcCtD
Betaxolol—Skin disorder—Niacin—atherosclerosis	0.000691	0.00147	CcSEcCtD
Betaxolol—Dyspnoea—Simvastatin—atherosclerosis	0.000691	0.00147	CcSEcCtD
Betaxolol—Hyperhidrosis—Niacin—atherosclerosis	0.000688	0.00147	CcSEcCtD
Betaxolol—Thrombocytopenia—Pravastatin—atherosclerosis	0.000686	0.00146	CcSEcCtD
Betaxolol—Feeling abnormal—Lovastatin—atherosclerosis	0.000683	0.00146	CcSEcCtD
Betaxolol—Dyspepsia—Simvastatin—atherosclerosis	0.000682	0.00146	CcSEcCtD
Betaxolol—Anorexia—Niacin—atherosclerosis	0.000679	0.00145	CcSEcCtD
Betaxolol—Hyperhidrosis—Pravastatin—atherosclerosis	0.000678	0.00145	CcSEcCtD
Betaxolol—Decreased appetite—Simvastatin—atherosclerosis	0.000674	0.00144	CcSEcCtD
Betaxolol—Feeling abnormal—Ezetimibe—atherosclerosis	0.00067	0.00143	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000669	0.00143	CcSEcCtD
Betaxolol—Diarrhoea—Rosuvastatin—atherosclerosis	0.000669	0.00143	CcSEcCtD
Betaxolol—Fatigue—Simvastatin—atherosclerosis	0.000668	0.00143	CcSEcCtD
Betaxolol—Anorexia—Pravastatin—atherosclerosis	0.000668	0.00142	CcSEcCtD
Betaxolol—Hypotension—Niacin—atherosclerosis	0.000665	0.00142	CcSEcCtD
Betaxolol—Constipation—Simvastatin—atherosclerosis	0.000663	0.00141	CcSEcCtD
Betaxolol—Pain—Simvastatin—atherosclerosis	0.000663	0.00141	CcSEcCtD
Betaxolol—Urticaria—Lovastatin—atherosclerosis	0.000658	0.0014	CcSEcCtD
Betaxolol—Body temperature increased—Lovastatin—atherosclerosis	0.000655	0.0014	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000649	0.00138	CcSEcCtD
Betaxolol—Dizziness—Rosuvastatin—atherosclerosis	0.000647	0.00138	CcSEcCtD
Betaxolol—Urticaria—Ezetimibe—atherosclerosis	0.000646	0.00138	CcSEcCtD
Betaxolol—Insomnia—Niacin—atherosclerosis	0.000644	0.00137	CcSEcCtD
Betaxolol—Body temperature increased—Ezetimibe—atherosclerosis	0.000643	0.00137	CcSEcCtD
Betaxolol—Paraesthesia—Niacin—atherosclerosis	0.000639	0.00136	CcSEcCtD
Betaxolol—Feeling abnormal—Simvastatin—atherosclerosis	0.000639	0.00136	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000639	0.00136	CcSEcCtD
Betaxolol—Dyspnoea—Niacin—atherosclerosis	0.000635	0.00135	CcSEcCtD
Betaxolol—Insomnia—Pravastatin—atherosclerosis	0.000634	0.00135	CcSEcCtD
Betaxolol—Paraesthesia—Pravastatin—atherosclerosis	0.000629	0.00134	CcSEcCtD
Betaxolol—Dyspepsia—Niacin—atherosclerosis	0.000627	0.00134	CcSEcCtD
Betaxolol—Dyspnoea—Pravastatin—atherosclerosis	0.000625	0.00133	CcSEcCtD
Betaxolol—Decreased appetite—Niacin—atherosclerosis	0.000619	0.00132	CcSEcCtD
Betaxolol—Dyspepsia—Pravastatin—atherosclerosis	0.000617	0.00132	CcSEcCtD
Betaxolol—Rash—Rosuvastatin—atherosclerosis	0.000617	0.00132	CcSEcCtD
Betaxolol—Dermatitis—Rosuvastatin—atherosclerosis	0.000616	0.00131	CcSEcCtD
Betaxolol—Urticaria—Simvastatin—atherosclerosis	0.000616	0.00131	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Niacin—atherosclerosis	0.000615	0.00131	CcSEcCtD
Betaxolol—Body temperature increased—Simvastatin—atherosclerosis	0.000613	0.00131	CcSEcCtD
Betaxolol—Headache—Rosuvastatin—atherosclerosis	0.000613	0.00131	CcSEcCtD
Betaxolol—Hypersensitivity—Lovastatin—atherosclerosis	0.000611	0.0013	CcSEcCtD
Betaxolol—Decreased appetite—Pravastatin—atherosclerosis	0.000609	0.0013	CcSEcCtD
Betaxolol—Pain—Niacin—atherosclerosis	0.000609	0.0013	CcSEcCtD
Betaxolol—Fatigue—Pravastatin—atherosclerosis	0.000604	0.00129	CcSEcCtD
Betaxolol—Constipation—Pravastatin—atherosclerosis	0.000599	0.00128	CcSEcCtD
Betaxolol—Pain—Pravastatin—atherosclerosis	0.000599	0.00128	CcSEcCtD
Betaxolol—Hypersensitivity—Ezetimibe—atherosclerosis	0.000599	0.00128	CcSEcCtD
Betaxolol—Asthenia—Lovastatin—atherosclerosis	0.000595	0.00127	CcSEcCtD
Betaxolol—Pruritus—Lovastatin—atherosclerosis	0.000586	0.00125	CcSEcCtD
Betaxolol—Asthenia—Ezetimibe—atherosclerosis	0.000583	0.00124	CcSEcCtD
Betaxolol—Nausea—Rosuvastatin—atherosclerosis	0.000581	0.00124	CcSEcCtD
Betaxolol—Feeling abnormal—Pravastatin—atherosclerosis	0.000578	0.00123	CcSEcCtD
Betaxolol—Pruritus—Ezetimibe—atherosclerosis	0.000575	0.00123	CcSEcCtD
Betaxolol—Hypersensitivity—Simvastatin—atherosclerosis	0.000571	0.00122	CcSEcCtD
Betaxolol—Diarrhoea—Lovastatin—atherosclerosis	0.000567	0.00121	CcSEcCtD
Betaxolol—Urticaria—Niacin—atherosclerosis	0.000565	0.00121	CcSEcCtD
Betaxolol—Body temperature increased—Niacin—atherosclerosis	0.000563	0.0012	CcSEcCtD
Betaxolol—Urticaria—Pravastatin—atherosclerosis	0.000557	0.00119	CcSEcCtD
Betaxolol—Asthenia—Simvastatin—atherosclerosis	0.000556	0.00119	CcSEcCtD
Betaxolol—Diarrhoea—Ezetimibe—atherosclerosis	0.000556	0.00119	CcSEcCtD
Betaxolol—Body temperature increased—Pravastatin—atherosclerosis	0.000554	0.00118	CcSEcCtD
Betaxolol—Pruritus—Simvastatin—atherosclerosis	0.000548	0.00117	CcSEcCtD
Betaxolol—Dizziness—Lovastatin—atherosclerosis	0.000548	0.00117	CcSEcCtD
Betaxolol—Dizziness—Ezetimibe—atherosclerosis	0.000538	0.00115	CcSEcCtD
Betaxolol—Diarrhoea—Simvastatin—atherosclerosis	0.00053	0.00113	CcSEcCtD
Betaxolol—Vomiting—Lovastatin—atherosclerosis	0.000527	0.00112	CcSEcCtD
Betaxolol—Hypersensitivity—Niacin—atherosclerosis	0.000524	0.00112	CcSEcCtD
Betaxolol—Rash—Lovastatin—atherosclerosis	0.000523	0.00111	CcSEcCtD
Betaxolol—Dermatitis—Lovastatin—atherosclerosis	0.000522	0.00111	CcSEcCtD
Betaxolol—Headache—Lovastatin—atherosclerosis	0.000519	0.00111	CcSEcCtD
Betaxolol—Vomiting—Ezetimibe—atherosclerosis	0.000517	0.0011	CcSEcCtD
Betaxolol—Hypersensitivity—Pravastatin—atherosclerosis	0.000516	0.0011	CcSEcCtD
Betaxolol—Dizziness—Simvastatin—atherosclerosis	0.000513	0.00109	CcSEcCtD
Betaxolol—Rash—Ezetimibe—atherosclerosis	0.000513	0.00109	CcSEcCtD
Betaxolol—Dermatitis—Ezetimibe—atherosclerosis	0.000512	0.00109	CcSEcCtD
Betaxolol—Asthenia—Niacin—atherosclerosis	0.000511	0.00109	CcSEcCtD
Betaxolol—Headache—Ezetimibe—atherosclerosis	0.000509	0.00109	CcSEcCtD
Betaxolol—Pruritus—Niacin—atherosclerosis	0.000504	0.00107	CcSEcCtD
Betaxolol—Asthenia—Pravastatin—atherosclerosis	0.000503	0.00107	CcSEcCtD
Betaxolol—Pruritus—Pravastatin—atherosclerosis	0.000496	0.00106	CcSEcCtD
Betaxolol—Vomiting—Simvastatin—atherosclerosis	0.000493	0.00105	CcSEcCtD
Betaxolol—Nausea—Lovastatin—atherosclerosis	0.000492	0.00105	CcSEcCtD
Betaxolol—Rash—Simvastatin—atherosclerosis	0.000489	0.00104	CcSEcCtD
Betaxolol—Dermatitis—Simvastatin—atherosclerosis	0.000488	0.00104	CcSEcCtD
Betaxolol—Diarrhoea—Niacin—atherosclerosis	0.000487	0.00104	CcSEcCtD
Betaxolol—Headache—Simvastatin—atherosclerosis	0.000486	0.00104	CcSEcCtD
Betaxolol—Nausea—Ezetimibe—atherosclerosis	0.000483	0.00103	CcSEcCtD
Betaxolol—Diarrhoea—Pravastatin—atherosclerosis	0.00048	0.00102	CcSEcCtD
Betaxolol—Dizziness—Niacin—atherosclerosis	0.000471	0.001	CcSEcCtD
Betaxolol—Dizziness—Pravastatin—atherosclerosis	0.000463	0.000989	CcSEcCtD
Betaxolol—Nausea—Simvastatin—atherosclerosis	0.00046	0.000982	CcSEcCtD
Betaxolol—Vomiting—Niacin—atherosclerosis	0.000453	0.000965	CcSEcCtD
Betaxolol—Rash—Niacin—atherosclerosis	0.000449	0.000957	CcSEcCtD
Betaxolol—Dermatitis—Niacin—atherosclerosis	0.000448	0.000956	CcSEcCtD
Betaxolol—Headache—Niacin—atherosclerosis	0.000446	0.000951	CcSEcCtD
Betaxolol—Vomiting—Pravastatin—atherosclerosis	0.000446	0.00095	CcSEcCtD
Betaxolol—Rash—Pravastatin—atherosclerosis	0.000442	0.000943	CcSEcCtD
Betaxolol—Dermatitis—Pravastatin—atherosclerosis	0.000442	0.000942	CcSEcCtD
Betaxolol—Headache—Pravastatin—atherosclerosis	0.000439	0.000936	CcSEcCtD
Betaxolol—Nausea—Niacin—atherosclerosis	0.000423	0.000902	CcSEcCtD
Betaxolol—Nausea—Pravastatin—atherosclerosis	0.000416	0.000888	CcSEcCtD
Betaxolol—ADRB1—Signaling Pathways—CX3CL1—atherosclerosis	4.92e-05	0.000835	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CX3CR1—atherosclerosis	4.91e-05	0.000833	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CASR—atherosclerosis	4.91e-05	0.000833	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—EDN1—atherosclerosis	4.88e-05	0.000827	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—CCL5—atherosclerosis	4.84e-05	0.00082	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CX3CL1—atherosclerosis	4.81e-05	0.000816	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—EDN1—atherosclerosis	4.77e-05	0.000809	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—CCL5—atherosclerosis	4.73e-05	0.000803	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CNR2—atherosclerosis	4.67e-05	0.000791	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—CXCL8—atherosclerosis	4.66e-05	0.000791	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—MMP3—atherosclerosis	4.65e-05	0.000789	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	4.63e-05	0.000786	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	4.61e-05	0.000781	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—PRKCG—atherosclerosis	4.6e-05	0.00078	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	4.58e-05	0.000776	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CNR2—atherosclerosis	4.56e-05	0.000774	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—CXCL8—atherosclerosis	4.56e-05	0.000774	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—MMP3—atherosclerosis	4.55e-05	0.000772	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PRKCG—atherosclerosis	4.5e-05	0.000763	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	4.47e-05	0.000758	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—EDN1—atherosclerosis	4.43e-05	0.000751	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—CCL5—atherosclerosis	4.39e-05	0.000745	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LTA4H—atherosclerosis	4.34e-05	0.000735	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ABCG8—atherosclerosis	4.34e-05	0.000735	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—EDN1—atherosclerosis	4.33e-05	0.000734	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—CCL5—atherosclerosis	4.3e-05	0.000729	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	4.28e-05	0.000726	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PRKCG—atherosclerosis	4.18e-05	0.000708	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—VWF—atherosclerosis	4.16e-05	0.000705	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOC3—atherosclerosis	4.13e-05	0.000701	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—LDLR—atherosclerosis	4.11e-05	0.000697	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PRKCG—atherosclerosis	4.09e-05	0.000693	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—VWF—atherosclerosis	4.07e-05	0.00069	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—AGT—atherosclerosis	4.05e-05	0.000686	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ABCG1—atherosclerosis	4.05e-05	0.000686	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	4.04e-05	0.000686	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOC3—atherosclerosis	4.04e-05	0.000686	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—LDLR—atherosclerosis	4.02e-05	0.000681	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCL3—atherosclerosis	4.01e-05	0.00068	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—AGT—atherosclerosis	3.96e-05	0.000671	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCL3—atherosclerosis	3.92e-05	0.000666	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NCF1—atherosclerosis	3.84e-05	0.000652	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—LCAT—atherosclerosis	3.8e-05	0.000645	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—FABP4—atherosclerosis	3.8e-05	0.000645	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NCF1—atherosclerosis	3.76e-05	0.000637	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—F2—atherosclerosis	3.74e-05	0.000634	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOA4—atherosclerosis	3.73e-05	0.000633	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—AGT—atherosclerosis	3.67e-05	0.000623	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP7A1—atherosclerosis	3.67e-05	0.000622	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—F2—atherosclerosis	3.66e-05	0.00062	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—EDNRA—atherosclerosis	3.63e-05	0.000615	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCR2—atherosclerosis	3.63e-05	0.000615	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CYBA—atherosclerosis	3.61e-05	0.000613	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	3.6e-05	0.000611	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—AGT—atherosclerosis	3.59e-05	0.00061	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—PIK3CG—atherosclerosis	3.58e-05	0.000607	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCR2—atherosclerosis	3.55e-05	0.000602	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—EDNRA—atherosclerosis	3.55e-05	0.000602	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PARP1—atherosclerosis	3.54e-05	0.0006	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PLAT—atherosclerosis	3.54e-05	0.0006	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GHRL—atherosclerosis	3.54e-05	0.0006	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CYBA—atherosclerosis	3.53e-05	0.000599	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	3.5e-05	0.000594	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PLAT—atherosclerosis	3.46e-05	0.000587	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PARP1—atherosclerosis	3.46e-05	0.000587	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GHRL—atherosclerosis	3.46e-05	0.000587	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ABCG1—atherosclerosis	3.43e-05	0.000581	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—F2—atherosclerosis	3.4e-05	0.000576	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP27A1—atherosclerosis	3.39e-05	0.000575	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—F2—atherosclerosis	3.32e-05	0.000563	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PIK3CG—atherosclerosis	3.25e-05	0.000551	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—FABP4—atherosclerosis	3.22e-05	0.000547	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LCAT—atherosclerosis	3.22e-05	0.000547	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	3.21e-05	0.000545	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOA2—atherosclerosis	3.21e-05	0.000545	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	3.21e-05	0.000545	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ALOX15—atherosclerosis	3.21e-05	0.000545	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	3.18e-05	0.000539	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ABCG5—atherosclerosis	3.18e-05	0.000538	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOA4—atherosclerosis	3.16e-05	0.000537	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP7A1—atherosclerosis	3.11e-05	0.000527	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—KNG1—atherosclerosis	3.1e-05	0.000526	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AGTR1—atherosclerosis	3.09e-05	0.000523	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—LPA—atherosclerosis	3.07e-05	0.00052	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—KNG1—atherosclerosis	3.04e-05	0.000515	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	3.03e-05	0.000513	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	3.02e-05	0.000512	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PLG—atherosclerosis	3.01e-05	0.00051	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—BGN—atherosclerosis	2.97e-05	0.000504	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.96e-05	0.000502	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	2.96e-05	0.000502	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PLG—atherosclerosis	2.94e-05	0.000499	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOA5—atherosclerosis	2.94e-05	0.000499	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP27A1—atherosclerosis	2.87e-05	0.000487	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	2.85e-05	0.000483	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	2.83e-05	0.00048	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.83e-05	0.00048	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	2.79e-05	0.000472	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.76e-05	0.000468	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MMP3—atherosclerosis	2.75e-05	0.000466	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IGF2—atherosclerosis	2.74e-05	0.000464	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ALOX5—atherosclerosis	2.73e-05	0.000464	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	2.72e-05	0.000462	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ALOX15—atherosclerosis	2.72e-05	0.000462	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOA2—atherosclerosis	2.72e-05	0.000462	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	2.72e-05	0.000462	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ABCG5—atherosclerosis	2.69e-05	0.000456	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MMP3—atherosclerosis	2.69e-05	0.000456	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.69e-05	0.000456	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IGF2—atherosclerosis	2.68e-05	0.000454	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOB—atherosclerosis	2.66e-05	0.000451	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	2.63e-05	0.000447	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—EDN1—atherosclerosis	2.62e-05	0.000444	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOB—atherosclerosis	2.6e-05	0.000441	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LPA—atherosclerosis	2.6e-05	0.000441	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCL5—atherosclerosis	2.6e-05	0.00044	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	2.58e-05	0.000437	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—EDN1—atherosclerosis	2.56e-05	0.000434	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCL5—atherosclerosis	2.54e-05	0.000431	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—LPL—atherosclerosis	2.54e-05	0.00043	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—BGN—atherosclerosis	2.52e-05	0.000427	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.5e-05	0.000424	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOA5—atherosclerosis	2.49e-05	0.000422	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—LPL—atherosclerosis	2.48e-05	0.000421	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	2.47e-05	0.000418	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NAMPT—atherosclerosis	2.45e-05	0.000416	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—LIPC—atherosclerosis	2.44e-05	0.000413	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOC3—atherosclerosis	2.42e-05	0.000411	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.42e-05	0.00041	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	2.41e-05	0.000409	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—LDLR—atherosclerosis	2.41e-05	0.000408	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SPP1—atherosclerosis	2.4e-05	0.000408	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	2.4e-05	0.000407	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	2.39e-05	0.000406	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.37e-05	0.000402	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SPP1—atherosclerosis	2.35e-05	0.000399	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CETP—atherosclerosis	2.35e-05	0.000399	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.35e-05	0.000398	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.34e-05	0.000397	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	2.34e-05	0.000397	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ALOX5—atherosclerosis	2.32e-05	0.000393	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SCARB1—atherosclerosis	2.25e-05	0.000382	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	2.22e-05	0.000377	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	2.18e-05	0.000369	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AGT—atherosclerosis	2.17e-05	0.000368	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.14e-05	0.000363	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—LEP—atherosclerosis	2.13e-05	0.000361	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOE—atherosclerosis	2.13e-05	0.000361	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HMGCR—atherosclerosis	2.13e-05	0.00036	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AGT—atherosclerosis	2.12e-05	0.00036	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CAV1—atherosclerosis	2.11e-05	0.000357	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOA1—atherosclerosis	2.1e-05	0.000357	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOE—atherosclerosis	2.08e-05	0.000353	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—LEP—atherosclerosis	2.08e-05	0.000353	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NAMPT—atherosclerosis	2.08e-05	0.000352	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.06e-05	0.00035	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LIPC—atherosclerosis	2.06e-05	0.00035	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CAV1—atherosclerosis	2.06e-05	0.00035	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOA1—atherosclerosis	2.06e-05	0.000349	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOC3—atherosclerosis	2.05e-05	0.000348	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LDLR—atherosclerosis	2.04e-05	0.000346	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ESR1—atherosclerosis	2.03e-05	0.000344	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—F2—atherosclerosis	2.01e-05	0.00034	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CETP—atherosclerosis	1.99e-05	0.000338	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ESR1—atherosclerosis	1.99e-05	0.000337	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—F2—atherosclerosis	1.96e-05	0.000333	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	1.92e-05	0.000326	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.91e-05	0.000323	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.89e-05	0.000321	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	1.88e-05	0.000318	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.86e-05	0.000315	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	1.84e-05	0.000312	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—INS—atherosclerosis	1.82e-05	0.000308	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HMGCR—atherosclerosis	1.8e-05	0.000305	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	1.8e-05	0.000305	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCL2—atherosclerosis	1.79e-05	0.000303	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—INS—atherosclerosis	1.78e-05	0.000301	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IGF1—atherosclerosis	1.76e-05	0.000298	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCL2—atherosclerosis	1.75e-05	0.000297	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IGF1—atherosclerosis	1.72e-05	0.000292	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	1.67e-05	0.000283	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	1.63e-05	0.000277	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.63e-05	0.000276	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.62e-05	0.000275	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ABCA1—atherosclerosis	1.61e-05	0.000272	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NOS3—atherosclerosis	1.59e-05	0.00027	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NOS3—atherosclerosis	1.56e-05	0.000264	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOB—atherosclerosis	1.56e-05	0.000264	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.51e-05	0.000257	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—LPL—atherosclerosis	1.49e-05	0.000252	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GPX1—atherosclerosis	1.45e-05	0.000246	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	1.41e-05	0.00024	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CD36—atherosclerosis	1.41e-05	0.00024	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	1.38e-05	0.000234	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HMOX1—atherosclerosis	1.38e-05	0.000234	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	1.37e-05	0.000232	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—IL6—atherosclerosis	1.34e-05	0.000228	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—MTHFR—atherosclerosis	1.34e-05	0.000227	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	1.34e-05	0.000227	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOB—atherosclerosis	1.32e-05	0.000224	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—IL6—atherosclerosis	1.31e-05	0.000223	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPARA—atherosclerosis	1.31e-05	0.000223	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GSTM1—atherosclerosis	1.28e-05	0.000218	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MMP9—atherosclerosis	1.28e-05	0.000217	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AGT—atherosclerosis	1.27e-05	0.000216	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	1.26e-05	0.000215	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LPL—atherosclerosis	1.26e-05	0.000214	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MMP9—atherosclerosis	1.25e-05	0.000212	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOE—atherosclerosis	1.25e-05	0.000211	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	1.24e-05	0.000211	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	1.24e-05	0.00021	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	1.24e-05	0.00021	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CAV1—atherosclerosis	1.23e-05	0.000209	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOA1—atherosclerosis	1.23e-05	0.000209	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GPX1—atherosclerosis	1.23e-05	0.000208	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	1.22e-05	0.000206	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	1.21e-05	0.000206	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CD36—atherosclerosis	1.2e-05	0.000203	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	1.15e-05	0.000195	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—STAT3—atherosclerosis	1.14e-05	0.000193	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—MTHFR—atherosclerosis	1.13e-05	0.000192	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PIK3CG—atherosclerosis	1.12e-05	0.000191	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	1.12e-05	0.00019	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPARA—atherosclerosis	1.11e-05	0.000189	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—STAT3—atherosclerosis	1.11e-05	0.000189	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	1.09e-05	0.000184	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPARG—atherosclerosis	1.09e-05	0.000184	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AGT—atherosclerosis	1.08e-05	0.000183	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—INS—atherosclerosis	1.06e-05	0.000181	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	1.06e-05	0.00018	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOE—atherosclerosis	1.06e-05	0.000179	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	1.05e-05	0.000179	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CAV1—atherosclerosis	1.05e-05	0.000177	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOA1—atherosclerosis	1.04e-05	0.000177	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	1.03e-05	0.000175	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ALB—atherosclerosis	9.76e-06	0.000166	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PIK3CG—atherosclerosis	9.53e-06	0.000162	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NOS3—atherosclerosis	9.34e-06	0.000158	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPARG—atherosclerosis	9.2e-06	0.000156	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—INS—atherosclerosis	9.02e-06	0.000153	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PTGS2—atherosclerosis	8.54e-06	0.000145	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ALB—atherosclerosis	8.27e-06	0.00014	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IL6—atherosclerosis	7.94e-06	0.000135	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NOS3—atherosclerosis	7.91e-06	0.000134	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IL6—atherosclerosis	7.77e-06	0.000132	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AKT1—atherosclerosis	7.33e-06	0.000124	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PTGS2—atherosclerosis	7.23e-06	0.000123	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AKT1—atherosclerosis	7.17e-06	0.000122	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AKT1—atherosclerosis	4.29e-06	7.28e-05	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AKT1—atherosclerosis	3.64e-06	6.17e-05	CbGpPWpGaD
